Basilea Pharmaceutica AG Stock
Stocks
BSLN
CH0011432447
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
18:30:19 20/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 65.60 CHF | +4.96% |
|
+24.71% | +19.93% |
| 08-18 | Basilea Pharmaceutica Ag Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-18 | Swiss Market Index Closes Higher; Huber+Suhner Shares Drop | MT |
| Market Cap | 814M 1.02B 872M 747M 1.4B 97.46B 1.43B 9.65B 3.76B 48.84B 3.82B 3.74B 162B | P/E 2026 * |
19.3x | P/E 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 664M 831M 711M 609M 1.14B 79.48B 1.17B 7.87B 3.07B 39.83B 3.12B 3.05B 132B | EV / Sales 2026 * |
2.55x | EV / Sales 2027 * | 2.22x |
| Free-Float |
91.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Basilea Pharmaceutica AG
| 1 day | +3.44% | ||
| 1 week | +24.71% | ||
| Current month | +26.40% | ||
| 1 month | +26.64% | ||
| 3 months | +23.77% | ||
| 6 months | +20.59% | ||
| Current year | +19.93% |
| 1 week | 52.7 |  | 65.6 |
| 1 month | 50.4 | | 65.6 |
| Current year | 47.8 | | 65.6 |
| 1 year | 44.7 | | 65.6 |
| 3 years | 32 | | 65.6 |
| 5 years | 29.55 | | 65.6 |
| 10 years | 29.28 | | 95.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Veitch
CEO | Chief Executive Officer | 61 | 19/04/2018 |
Adesh Kaul
DFI | Director of Finance/CFO | 52 | 10/04/2019 |
Gerrit Hauck
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/05/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Werner
BRD | Director/Board Member | 70 | 29/11/2011 |
| Chairman | 71 | 09/04/2013 | |
Nicole Onetto
BRD | Director/Board Member | 73 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/29/26 A | Sell | -400 | 0.0030% | |||
| 2/25/26 A | Fiscal year | 1,500 | 0.0113% | |||
| 2/20/26 A | Sell | 600 | 0.0045% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.96% | +24.71% | +34.15% | +39.13% | 968M | |
| +1.14% | +3.46% | +4.57% | +24.14% | 50.5B | |
| -1.36% | +3.15% | +479.46% | +614.84% | 46.01B | |
| -2.04% | +2.82% | +18.13% | +91.23% | 42.85B | |
| +2.72% | +5.93% | +33.12% | +19.66% | 41.03B | |
| 0.00% | -3.91% | +17.87% | +47.98% | 32.02B | |
| +0.72% | +2.62% | +32.57% | +145.37% | 16.98B | |
| -1.85% | -0.25% | - | - | 17.05B | |
| +3.06% | +4.63% | +7.40% | +35.00% | 14.3B | |
| +0.50% | +2.49% | +83.90% | +46.53% | 13.84B | |
| Average | +0.69% | +3.69% | +79.02% | +118.21% | 27.56B | |
| Weighted average by Cap. | +0.30% | +2.43% | +103.87% | +152.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 261M 326M 279M 239M 449M 31.22B 458M 3.09B 1.21B 15.65B 1.23B 1.2B 51.8B | 271M 339M 290M 248M 466M 32.4B 476M 3.21B 1.25B 16.24B 1.27B 1.24B 53.76B |
| Net income | 53.56M 67.04M 57.4M 49.14M 92.34M 6.41B 94.16M 635M 248M 3.21B 252M 246M 10.64B | 44.43M 55.62M 47.62M 40.77M 76.61M 5.32B 78.12M 527M 205M 2.67B 209M 204M 8.83B |
| Net Debt | -150M -188M -161M -138M -259M -17.98B -264M -1.78B -694M -9.01B -705M -690M -29.82B | -214M -267M -229M -196M -368M -25.6B -376M -2.54B -988M -12.83B -1B -983M -42.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/08/26 | CHF 65.60 | +4.96% | 174,654 |
| 19/08/26 | CHF 62.50 | +4.87% | 207,024 |
| 18/08/26 | CHF 59.60 | +9.96% | 258,145 |
| 17/08/26 | CHF 54.20 | +2.07% | 26,954 |
| 14/08/26 | CHF 53.10 | +0.19% | 29,468 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSLN Stock
Select your edition
All financial news and data tailored to specific country editions
